首页> 外文OA文献 >15-deoxy-Delta12,14-prostaglandin J2 inhibits the expression of microsomal prostaglandin E synthase type 2 in colon cancer cells
【2h】

15-deoxy-Delta12,14-prostaglandin J2 inhibits the expression of microsomal prostaglandin E synthase type 2 in colon cancer cells

机译:15-deoxy-Delta12,14-prostaglandin J2抑制结肠癌细胞中2型微粒体前列腺素E合酶的表达

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Prostaglandin (PG) E(2) (PGE(2)) plays a predominant role in promoting colorectal carcinogenesis. The biosynthesis of PGE(2) is accomplished by conversion of the cyclooxygenase (COX) product PGH(2) by several terminal prostaglandin E synthases (PGES). Among the known PGES isoforms, microsomal PGES type 1 (mPGES-1) and type 2 (mPGES-2) were found to be overexpressed in colorectal cancer (CRC); however, the role and regulation of these enzymes in this malignancy are not yet fully understood. Here, we report that the cyclopentenone prostaglandins (CyPGs) 15-deoxy-Delta(12,14)-PGJ(2) and PGA(2) downregulate mPGES-2 expression in the colorectal carcinoma cell lines Caco-2 and HCT 116 without affecting the expression of any other PGES or COX. Inhibition of mPGES-2 was subsequently followed by decreased microsomal PGES activity. These effects were mediated via modulation of the cellular thiol-disulfide redox status but did not involve activation of the peroxisome proliferator-activated receptor gamma or PGD(2) receptors. CyPGs had antiproliferative properties in vitro; however, this biological activity could not be directly attributed to decreased PGES activity because it could not be reversed by adding PGE(2). Our data suggest that there is a feedback mechanism between PGE(2) and CyPGs that implicates mPGES-2 as a new potential target for pharmacological intervention in CRC.
机译:前列腺素(PG)E(2)(PGE(2))在促进结直肠癌发生中起主要作用。 PGE(2)的生物合成是通过几种末端前列腺素E合酶(PGES)转化环氧合酶(COX)产品PGH(2)来完成的。在已知的PGES亚型中,发现1型微粒体PGES(mPGES-1)和2型微粒体(mPGES-2)在结直肠癌(CRC)中过表达。然而,这些酶在恶性肿瘤中的作用和调控尚不完全清楚。在这里,我们报告环戊烯酮前列腺素(CyPGs)15-deoxy-Delta(12,14)-PGJ(2)和PGA(2)下调大肠癌细胞系Caco-2和HCT 116中的mPGES-2表达任何其他PGES或COX的表达。随后抑制mPGES-2,然后降低微粒体PGES活性。这些影响是通过调节细胞硫醇-二硫键的氧化还原状态介导的,但不涉及过氧化物酶体增殖物激活受体γ或PGD(2)受体的激活。 CyPG具有体外抗增殖特性;但是,这种生物学活性不能直接归因于PGES活性降低,因为不能通过添加PGE(2)来逆转。我们的数据表明,PGE(2)和CyPG之间存在一种反馈机制,暗示mPGES-2是CRC药理干预的新潜在靶点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号